A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures

Background Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or allevia...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 34; no. S2; pp. 3 - 11
Main Authors Reich, A., Lopez Estebaranz, J.L., Bahadoran, P., Guillot, P., Carballido, F., Saint Aroman, M.
Format Journal Article
LanguageEnglish
Published England 01.06.2020
Subjects
Online AccessGet full text
ISSN0926-9959
1468-3083
1468-3083
DOI10.1111/jdv.16428

Cover

Abstract Background Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms. Objectives Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures. Methods Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment‐emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre‐ and postapplication. Results A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies. Conclusions The dermo‐cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.
AbstractList Background Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post‐acts) can result in intense itching and cutaneous pain. Dermo‐cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms. Objectives Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures. Methods Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment‐emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre‐ and postapplication. Results A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies. Conclusions The dermo‐cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.
Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms. Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures. Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication. A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies. The dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.
Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.BACKGROUNDInflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.OBJECTIVESAssessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication.METHODSData from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication.A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.RESULTSA total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.The dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.CONCLUSIONSThe dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.
Author Saint Aroman, M.
Reich, A.
Guillot, P.
Carballido, F.
Lopez Estebaranz, J.L.
Bahadoran, P.
Author_xml – sequence: 1
  givenname: A.
  orcidid: 0000-0002-5573-1754
  surname: Reich
  fullname: Reich, A.
  organization: University of Rzeszow
– sequence: 2
  givenname: J.L.
  surname: Lopez Estebaranz
  fullname: Lopez Estebaranz, J.L.
  organization: University Hospital Fundacion Alcorcon
– sequence: 3
  givenname: P.
  surname: Bahadoran
  fullname: Bahadoran, P.
  organization: Hôpital de l’Archet
– sequence: 4
  givenname: P.
  surname: Guillot
  fullname: Guillot, P.
  organization: Wallerstein Medical Center
– sequence: 5
  givenname: F.
  surname: Carballido
  fullname: Carballido, F.
  organization: Pierre Fabre Dermo‐Cosmétique
– sequence: 6
  givenname: M.
  orcidid: 0000-0001-6124-5122
  surname: Saint Aroman
  fullname: Saint Aroman, M.
  email: marketa.saint.aroman@pierre-fabre.com
  organization: Pierre Fabre Dermo‐Cosmétique
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32476176$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1O3TAQha2KqlxoF32BysuyCNhO4jhLRP-F1A2wjeZOJmDq2KntC9zH6ZvW9NIuKrX2YqTxN2d0fA7Yng-eGHstxbEs5-R2vDuWulHmGVvJRpuqFqbeYyvRK131fdvvs4OUboUQUrbmBduvVdNp2ekV-3HK0xJhyzH4DNZbf83pIUfAnHiYeIDMFwc-OyoN8CO_9AjRAs9hJp9DAh7JWbqjxJciwCGlgBYyjfze5huONzF4i9z6ycE8Qw5xy9O3Qo42ESTayY4UH99cuLYIji8xII2bSOklez6BS_TqqR6yyw_vL84-VedfP34-Oz2vsNbCVKoFUhqLLYmqFGhBqV6A7rpGN2ujFE2oWql7s1aAAsF0zTgZhVNLY4P1IXu70y2rv28o5WG2CckV8xQ2aVCNMG3dl1vQN0_oZj3TOCzRzhC3w-9vLcDRDsAYUoo0_UGkGB4jG0pkw6_ICnvyF4s2Q7YljwjW_W_i3jra_lt6-PLuajfxE7k8q6w
CitedBy_id crossref_primary_10_1111_jdv_18740
crossref_primary_10_3390_molecules26185564
crossref_primary_10_56083_RCV3N11_143
crossref_primary_10_1111_jdv_17876
Cites_doi 10.1055/s-0030-1250649
10.1016/j.pbb.2005.04.004
10.1201/b16573-10
10.1155/2019/3706315
10.1002/ejp.768
10.2147/CCID.S177614
10.1111/jdv.14891
10.1007/s00424-013-1284-2
10.1186/s40535-014-0003-1
10.1016/j.anai.2017.09.076
10.1248/bpb.28.601
10.1016/j.jid.2019.03.715
10.1111/ajd.12715
10.3390/antiox6010012
10.1016/j.sder.2010.03.001
10.2340/00015555-1965
10.1111/jdv.14410
10.1007/s13555-019-0280-7
10.3390/biomedicines6010012
10.1111/jdv.14846
10.1007/s40271-019-00373-y
10.1111/jdv.14077
10.1016/S0140-6736(15)00149-X
10.1007/s00018-015-1904-4
10.1159/000446009
10.1007/PL00000268
ContentType Journal Article
Copyright 2020 European Academy of Dermatology and Venereology
2020 European Academy of Dermatology and Venereology.
Copyright_xml – notice: 2020 European Academy of Dermatology and Venereology
– notice: 2020 European Academy of Dermatology and Venereology.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jdv.16428
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3083
EndPage 11
ExternalDocumentID 32476176
10_1111_jdv_16428
JDV16428
Genre article
Journal Article
GroupedDBID ---
--K
.3N
.GA
.Y3
05W
0R~
10A
1B1
1OB
1OC
1~5
29L
31~
33P
36B
3SF
4.4
4G.
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AALRI
AAMNL
AANHP
AANLZ
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABQWH
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADZMN
AE3
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFTJW
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CO8
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FDB
FEDTE
FGOYB
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
NQ-
O66
O9-
OIG
OVD
OZT
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
R2-
RIG
RIWAO
RJQFR
ROL
RPZ
RX1
SAMSI
SEW
SUPJJ
TEORI
UB1
UHS
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
ACVFH
ADCNI
AEUPX
AEYWJ
AFPUW
AGHNM
AGQPQ
AGYGG
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3608-25ae26c7611c2c76a5a2290a677464b822efc251698b2ac0ca874df82cf5ed4c3
IEDL.DBID DR2
ISSN 0926-9959
1468-3083
IngestDate Fri Jul 11 07:17:45 EDT 2025
Thu Apr 03 07:04:43 EDT 2025
Tue Jul 01 04:12:08 EDT 2025
Thu Apr 24 22:52:25 EDT 2025
Wed Jan 22 16:35:24 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S2
Language English
License 2020 European Academy of Dermatology and Venereology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3608-25ae26c7611c2c76a5a2290a677464b822efc251698b2ac0ca874df82cf5ed4c3
Notes AR has been a consultant or speaker for AbbVie, Bioderma, Celgene, Chema Elektromet, Eli Lilly, Galderma, Janssen, Leo Pharma, Medac, Menlo Therapeutics, Novartis, Pierre‐Fabre, Sandoz and Trevi; and a principal Investigator or sub‐investigator in clinical trials sponsored by AbbVie, Drug Delivery Solutions Ltd, Galderma, Genentech, Janssen, Kymab Limited, Leo Pharma, Menlo Therapeutics, MetrioPharm, MSD, Novartis, Pfizer and Trev. JLE has been a consultant or speaker for Abbvie, Novartis, Leo, Galderma, Lilly, Janssen and Almirall. PB has received honoraria as a speaker from Pierre Fabre Dermo‐Cosmétique and has been reimbursed by Pierre Fabre Dermo‐Cosmétique for international conference attendance. FC and MSA work within the Pierre Fabre Dermo‐Cosmétique company, in the A‐DERMA brand. PG declares no COIs.
Conflicts of interest
Funding sources
This study was funded by Pierre Fabre Dermo‐Cosmétique.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5573-1754
0000-0001-6124-5122
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.16428
PMID 32476176
PQID 2408539393
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2408539393
pubmed_primary_32476176
crossref_primary_10_1111_jdv_16428
crossref_citationtrail_10_1111_jdv_16428
wiley_primary_10_1111_jdv_16428_JDV16428
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2020
2020-06-00
2020-Jun
20200601
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: June 2020
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the European Academy of Dermatology and Venereology
PublicationTitleAlternate J Eur Acad Dermatol Venereol
PublicationYear 2020
References 2017; 119
2017; 6
2019; 2019
2019; 9
2001; 50
2013; 87
2015; 95
2015; 72
2019; 12
2016; 387
2011; 77
2013; 465
2016; 50
2005; 81
2005; 28
2014; 1
2018; 6
2017; 31
2010; 29
2019
2016; 20
2014
2018; 11
2018; 32
2018; 59
Saint Aroman M (e_1_2_6_16_1) 2018; 11
e_1_2_6_10_1
e_1_2_6_19_1
e_1_2_6_14_1
Weigle N (e_1_2_6_11_1) 2013; 87
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_21_1
e_1_2_6_20_1
Borgia F (e_1_2_6_13_1) 2018; 6
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 95
  start-page: 432
  year: 2015
  end-page: 438
  article-title: Psoriasis and skin pain: instrumental and biological evaluations
  publication-title: Acta Derm Venereol
– volume: 9
  start-page: 71
  year: 2019
  end-page: 102
  article-title: Tolerability of topical treatments for atopic dermatitis
  publication-title: Dermatol Ther (Heidelb)
– volume: 119
  start-page: 548
  year: 2017
  end-page: 552
  article-title: Burden of skin pain in atopic dermatitis
  publication-title: Ann Allergy Asthma Immunol
– volume: 81
  start-page: 466
  year: 2005
  end-page: 477
  article-title: Involvement of 5‐HT2 receptors in the antinociceptive effect of
  publication-title: Pharmacol Biochem Behav
– volume: 2019
  start-page: 15
  year: 2019
  article-title: Skin acute wound healing: a comprehensive review
  publication-title: Int J Inflamm
– volume: 1
  start-page: 3
  year: 2014
  article-title: The immunological and genetic aspects in psoriasis
  publication-title: Appl Inform
– volume: 6
  year: 2018
  article-title: Early and late onset side effects of photodynamic therapy
  publication-title: Biomedicines
– volume: 11
  start-page: 579
  year: 2018
  end-page: 589
  article-title: Efficacy of a repair cream containing Rhealba oat plantlets extract l‐ALA‐l‐GLU dipeptide, and hyaluronic acid in wound healing following dermatological acts: a meta‐analysis of >2,000 patients in eight countries corroborated by a dermatopediatric clinical case
  publication-title: Clin Cosmet Investig Dermatol
– volume: 465
  start-page: 1671
  year: 2013
  end-page: 1685
  article-title: New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?
  publication-title: Pflugers Arch
– volume: 32
  start-page: 1
  issue: Suppl 1
  year: 2018
  end-page: 15
  article-title: Effects of a protein‐free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients
  publication-title: J Eur Acad Dermatol Venereol
– volume: 50
  start-page: 442
  year: 2001
  end-page: 448
  article-title: Efficacy and safety of freeze‐dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species
  publication-title: Inflamm Res
– year: 2014
– volume: 6
  start-page: 12
  year: 2017
  article-title: Proanthocyanidin characterization and bioactivity of extracts from different parts of L. (Cat’s Claw)
  publication-title: Antioxidants (Basel)
– volume: 31
  start-page: 3
  issue: Suppl 6
  year: 2017
  end-page: 18
  article-title: Fragility of epidermis: acne and post‐procedure lesional skin
  publication-title: J Eur Acad Dermatol Venereol
– volume: 32
  start-page: 657
  year: 2018
  end-page: 682
  article-title: Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
  publication-title: J Eur Acad Dermatol Venereol
– volume: 29
  start-page: 3
  year: 2010
  end-page: 9
  article-title: New insights in the immunologic basis of psoriasis
  publication-title: Semin Cutan Med Surg
– volume: 20
  start-page: 41
  year: 2016
  end-page: 46
  article-title: Pruritus in psoriasis: An update
  publication-title: Eur J Pain
– volume: 28
  start-page: 601
  year: 2005
  end-page: 606
  article-title: Avena Rhealba inhibits A23187‐stimulated arachidonic acid mobilization, eicosanoid release, and cPLA2 expression in human keratinocytes: potential in cutaneous inflammatory disorders
  publication-title: Biol Pharm Bull
– volume: 72
  start-page: 3201
  year: 2015
  end-page: 3223
  article-title: Molecular and cellular mechanisms that initiate pain and itch
  publication-title: Cell Mol Life Sci
– volume: 50
  start-page: 1
  year: 2016
  end-page: 4
  article-title: Classification of Itch
  publication-title: Curr Probl Dermatol
– volume: 77
  start-page: 900
  year: 2011
  end-page: 906
  article-title: Rhealba\xAE oat plantlet extract: evidence of protein‐free content and assessment of regulatory activity on immune inflammatory mediators
  publication-title: Planta Med
– volume: 87
  start-page: 626
  year: 2013
  end-page: 633
  article-title: Psoriasis
  publication-title: Am Fam Physician.
– volume: 31
  start-page: 1
  issue: Suppl 1
  year: 2017
  end-page: 7
  article-title: Efficacy of a Rhealba Oat Extract-based emollient on chronic pruritus in elderly French outpatients. Oat Extract‐based emollient on chronic pruritus in elderly French outpatients
  publication-title: J Eur Acad Dermatol Venereol
– year: 2019
– volume: 12
  start-page: 445
  year: 2019
  end-page: 459
  article-title: Patient‐reported outcome measures in atopic dermatitis and chronic hand eczema in adults
  publication-title: Patient
– volume: 387
  start-page: 1109
  year: 2016
  end-page: 1122
  article-title: Atopic dermatitis
  publication-title: Lancet
– volume: 59
  start-page: 171
  year: 2018
  end-page: 181
  article-title: Chemical peels: A review of current practice
  publication-title: Australas J Dermatol
– ident: e_1_2_6_17_1
  doi: 10.1055/s-0030-1250649
– ident: e_1_2_6_20_1
  doi: 10.1016/j.pbb.2005.04.004
– ident: e_1_2_6_4_1
  doi: 10.1201/b16573-10
– ident: e_1_2_6_5_1
  doi: 10.1155/2019/3706315
– ident: e_1_2_6_26_1
  doi: 10.1002/ejp.768
– volume: 11
  start-page: 579
  year: 2018
  ident: e_1_2_6_16_1
  article-title: Efficacy of a repair cream containing Rhealba oat plantlets extract l‐ALA‐l‐GLU dipeptide, and hyaluronic acid in wound healing following dermatological acts: a meta‐analysis of >2,000 patients in eight countries corroborated by a dermatopediatric clinical case
  publication-title: Clin Cosmet Investig Dermatol
  doi: 10.2147/CCID.S177614
– ident: e_1_2_6_22_1
  doi: 10.1111/jdv.14891
– ident: e_1_2_6_3_1
  doi: 10.1007/s00424-013-1284-2
– ident: e_1_2_6_9_1
  doi: 10.1186/s40535-014-0003-1
– volume: 87
  start-page: 626
  year: 2013
  ident: e_1_2_6_11_1
  article-title: Psoriasis
  publication-title: Am Fam Physician.
– ident: e_1_2_6_7_1
  doi: 10.1016/j.anai.2017.09.076
– ident: e_1_2_6_23_1
  doi: 10.1248/bpb.28.601
– ident: e_1_2_6_21_1
  doi: 10.1016/j.jid.2019.03.715
– ident: e_1_2_6_14_1
  doi: 10.1111/ajd.12715
– ident: e_1_2_6_24_1
  doi: 10.3390/antiox6010012
– ident: e_1_2_6_8_1
  doi: 10.1016/j.sder.2010.03.001
– ident: e_1_2_6_27_1
  doi: 10.2340/00015555-1965
– ident: e_1_2_6_15_1
  doi: 10.1111/jdv.14410
– ident: e_1_2_6_6_1
  doi: 10.1007/s13555-019-0280-7
– volume: 6
  year: 2018
  ident: e_1_2_6_13_1
  article-title: Early and late onset side effects of photodynamic therapy
  publication-title: Biomedicines
  doi: 10.3390/biomedicines6010012
– ident: e_1_2_6_19_1
  doi: 10.1111/jdv.14846
– ident: e_1_2_6_28_1
  doi: 10.1007/s40271-019-00373-y
– ident: e_1_2_6_18_1
  doi: 10.1111/jdv.14077
– ident: e_1_2_6_10_1
  doi: 10.1016/S0140-6736(15)00149-X
– ident: e_1_2_6_2_1
  doi: 10.1007/s00018-015-1904-4
– ident: e_1_2_6_12_1
  doi: 10.1159/000446009
– ident: e_1_2_6_25_1
  doi: 10.1007/PL00000268
SSID ssj0001158
Score 2.298159
Snippet Background Inflammation from skin conditions such as psoriasis, eczema‐like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures...
Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3
SubjectTerms Avena - chemistry
Cat's Claw - chemistry
Chronic Disease
Dermatitis - complications
Dermatitis - drug therapy
Humans
Pain - drug therapy
Pain - etiology
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Title A spray containing extracts of oat plantlets and Uncaria tomentosa relieves pain associated with chronic inflammatory skin diseases and dermatological procedures
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.16428
https://www.ncbi.nlm.nih.gov/pubmed/32476176
https://www.proquest.com/docview/2408539393
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swECYMD0GXNo8-3DTBpejQRYYlUZSMTkHcwDDgDEFdeCggnEhqsSsJpmwg_Tf9pzlSktv0AQSBBmk4HUjxHh951EfGPvAEhYxz7nGV0AQlktIbZxn3JA9j5Ys80W7BbX4jpgs-W0bLHvvU_QvT8EPsF9ysZ7h4bR0cM_O7k6vd0LfomeKvHwrLmz-5_UUdRUjHReFxIDzLqdWyCrldPN2bD3PRXwDzIV51Cef6BfvWNbXZZ7IabutsKH_8weL4xL4csuctEIXLxnKOWE8Xx-xg3pbaT9jPSzDVBu_AbmZvjpEACuT2pyoDZQ4l1lCtaVxo4A1goWBRSJp4I9SW1KEuDcKGmqV32kBFCgBbS9AK7OovyIaXF8jGySy_u3I_mBVJtlWjRq2yuaPuYjS4jKu2G21essX15y9XU689z8GToRiRQ0aoA7IM4fsyoBtGaNnmURAEFTwjqKJzGdjCXZIFKEcSk5irPAlkHmnFZfiK9Yuy0G8Y5GOFOsJYkxJOIRKzPIm1DoXlswvjaMA-diObypbs3J65sU73kx61S90nH7D3e9GqYfj4l9BFZx4p-Z8tqmChy61JHUVcOKZrwF43drNXQ2CVOhsLao0b_f_rT2eTr-7h7eNFT9mzwE7-3ZLQO9avN1t9Rgipzs6dK9wDRAAQNw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgGX8mrp8hwQBy5ZdRPHyUpcKkq1lG4PqIt6QdHEdi5tk9UmuxL8G_4pM06yUB5ShXJIDs7IjmfG38w4nwFeq5S0SQoVKJtygBIbE4zzXAVGRYkd6SJ1PuE2PdGTmTo6i8824G3_L0zLD7FOuIlleH8tBi4J6V-t3K6GI4HPN-CmYqAhodfBp5_kUYx1vB8ehzoQVq2OV8jv4-lfvboa_QExryJWv-Qc3oUvfWfbnSbnw2WTD82333gc_3c092Crw6K43yrPfdhw5QO4Ne2q7Q_h-z7W8wV9RdnP3p4kgezL5b-qGqsCK2pwfsFTw3NfI5UWZ6Xh2JuwEV6HpqoJF9wvt3I1zlkAUqcMzqIkgNG01LzIas6aeekr_lifc8uucNSKtbJ8NL2bRr_o2uXC1dswO3x_-m4SdEc6BCbSe2yTMbmQlUOPRibkG8UkhPOkGYVqlTNacYUJpXaX5iGZPUNpomyRhqaInVUm2oHNsirdLmAxtuRiShwLUewlKS_SxLlIC6VdlMQDeNNPbWY6vnM5duMiW8c9dpX5Tz6AV-um85bk42-NXvb6kbEJSl2FSlct68yzxEVjvgbwqFWctRjGqzzYRHNv_PT_W352dPDZPzy-ftMXcHtyOj3Ojj-cfHwCd0LJBfgM0VPYbBZL94wBU5M_93bxAzPGFFY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq4lJZXt7QwIA5csmITx8mqp6pl1RZaIcSiHpCiiR-Xtkm0ya4E_4Z_ythJthSohFAOycEZ2ZmHP884nwFei5SkSqwIhE55gRIrFYzzXARKRIkeSZsan3A7O5fHU3F6EV-swH7_L0zLD7FMuDnP8PHaOXil7a9OrhfDkUPP92BNSEYSDhF9uuGOYqjjw_A4lIEj1epohfw2nv7V25PRHwjzNmD1M87kAXzt-9puNLkczpt8qL7_RuP4n4PZhI0OieJBazpbsGKKh7B-1tXaH8GPA6yrGX1Dt5u9PUcCOZK7v6pqLC2W1GB1xYphzddIhcZpoXjlTdg4VoemrAln3C2zMDVWLACpMwWj0aV_UbXEvMhGznZ57ev9WF9yy65s1IrVbvJo-iCNfsrV85mpH8N08u7z4XHQHegQqIg1FIQxmZBNQ45GKuQbxeTo5kkyBpUiZ6xirApd5S7NQ1JvFaWJ0DYNlY2NFip6AqtFWZhtQDvWZGJKDAsRHCMpt2liTCQdoV2UxAN402s2Ux3buTt04ypbrnr0IvOffACvlk2rluLjb41e9uaRsQO6qgoVppzXmeeIi8Z8DeBpazdLMYxWebCJ5N547d8tPzs9-uIfdv696QtY_3g0yT6cnL9_BvdDlwjw6aFdWG1mc7PHaKnJn3uv-An2NBMF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+spray+containing+extracts+of+oat+plantlets+and+Uncaria+tomentosa+relieves+pain+associated+with+chronic+inflammatory+skin+diseases+and+dermatological+procedures&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Reich%2C+A.&rft.au=Lopez+Estebaranz%2C+J.L.&rft.au=Bahadoran%2C+P.&rft.au=Guillot%2C+P.&rft.date=2020-06-01&rft.issn=0926-9959&rft.eissn=1468-3083&rft.volume=34&rft.spage=3&rft.epage=11&rft_id=info:doi/10.1111%2Fjdv.16428&rft.externalDBID=10.1111%252Fjdv.16428&rft.externalDocID=JDV16428
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon